Factors for the Optimal Selection of Granulocyte Colony-stimulating Factor Preparations and Predictors for R-CHOP Dose Reductions/delays Among Patients with Non-Hodgkin B-cell Lymphoma (STOP FN in NHL 2 Subanalysis)

BMC Cancer

Relevant factors for G-CSF preparation selection were age ≥ 80 years and LC < 1000 cells/μL. The use of pegfilgrastim increased markedly after cycle 2. These results may be useful for selecting appropriate G-CSF preparations in the first R-CHOP cycle.